Long-term treatment with proton pump inhibitor is associated with undesired weight gain

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

366

HTML

3118

Figures (1-1)

Tables (1-3)

Sum=3484

Oct 14, 2009 (publication date) through Dec 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Oct 14, 2009; 15(38): 4794-4798
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4794

Table 2 Patient demographics

	Patients (n = 52)
Helicobacter pylori status
Negative	9
Positive	11
ND	32
Endoscopic findings
Normal	18
LA grade A	6
LA grade B	13
LA grade C	5
LA grade D	3
ND	7
Number of patients according to PPI regimens
Omeprazole 10 mg once daily	24
Omeprazole 20 mg once daily	12
Rabeprazole 10 mg once daily	8
Lansoprazole 15 mg once daily	5
Lansoprazole 30 mg once daily	3

LA: Los Angeles classification; ND: Not determined.

Citation: Yoshikawa I, Nagato M, Yamasaki M, Kume K, Otsuki M. Long-term treatment with proton pump inhibitor is associated with undesired weight gain. World J Gastroenterol 2009; 15(38): 4794-4798
URL: https://www.wjgnet.com/1007-9327/full/v15/i38/4794.htm
DOI: https://dx.doi.org/10.3748/wjg.15.4794